However, it is not known if mTOR phosphorylation is involved, via chronic fluoxetine administration, in the reversal of the depression-like behaviors, nor is it understood whether mTOR phosphorylation is necessary for synaptic protein expression. The gene discussed is MTOR; the disease is depressive symptom measurement.